Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG: 9989)

Shenzhen Hepalink Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16,373	16,905	19,320	27,970	28,112	27,220
Market Cap Growth	-4.04%	-12.50%	-30.93%	-0.50%	3.27%	-16.84%
Enterprise Value	17,771	21,024	22,600	29,804	30,748	32,568
Last Close Price	4.09	3.58	5.33	7.90	11.30	-
PE Ratio	-	-	23.49	94.63	23.11	22.97
PS Ratio	2.76	2.82	2.39	3.58	4.44	5.26
PB Ratio	1.23	1.28	1.38	1.98	2.03	3.26
P/TBV Ratio	1.60	1.68	1.81	2.62	2.70	5.63
P/FCF Ratio	7.11	-	-	-	-	-
P/OCF Ratio	6.20	38.53	-	-	634.89	-
EV/Sales Ratio	3.04	3.50	2.79	3.81	4.86	6.30
EV/EBITDA Ratio	55.18	223.24	15.71	22.00	20.11	29.04
EV/EBIT Ratio	-	-	20.02	29.13	25.54	38.98
EV/FCF Ratio	7.59	-	-	-	-	-
Debt / Equity Ratio	0.35	0.46	0.52	0.49	0.48	0.84
Debt / EBITDA Ratio	14.34	46.80	4.95	4.98	4.28	6.28
Debt / FCF Ratio	2.04	-	-	-	-	-
Asset Turnover	0.29	0.27	0.36	0.33	0.31	0.32
Inventory Turnover	0.67	0.67	0.84	1.11	1.19	1.46
Quick Ratio	1.01	0.73	0.93	1.19	1.52	0.62
Current Ratio	2.39	2.13	2.22	2.25	2.53	1.21
Return on Equity (ROE)	-1.34%	-6.58%	5.98%	2.01%	10.66%	15.30%
Return on Assets (ROA)	-0.31%	-0.74%	3.13%	2.73%	3.70%	3.24%
Return on Capital (ROIC)	-0.34%	-0.82%	3.46%	3.02%	4.07%	3.76%
Earnings Yield	-0.97%	-5.10%	4.26%	1.06%	4.33%	4.35%
FCF Yield	14.06%	-0.30%	-5.73%	-0.88%	-0.74%	-2.42%
Dividend Yield	0.00%	-	2.12%	0.54%	1.58%	-
Payout Ratio	0.00%	-	34.51%	171.31%	43.69%	32.33%
Buyback Yield / Dilution	0.01%	0.05%	-0.05%	-8.42%	-8.51%	0.01%
Total Shareholder Return	0.01%	0.05%	2.07%	-7.88%	-6.94%	0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.